ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,741Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 1111

$632K Total Retail Price of All Prescriptions

Rank: 132 out of 1111

463 Patients Receiving at Least One Drug in Part D
33%Patients 65 Years and Older
92% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

68% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

3% of this provider’s 5,191 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
HYDROCODONE-ACETAMINOPHEN 2,688 665 S3 1 1
LISINOPRIL-HYDROCHLOROTHIAZIDE 754 193 2 23
ZOLPIDEM TARTRATE 580 129 3 16
LISINOPRIL 421 201 4 2
AMLODIPINE BESYLATE 411 174 5 7
SIMVASTATIN 319 152 6 5
NAPROXEN 309 102 7 85
FUROSEMIDE 306 129 8 6
CARISOPRODOL 299 12 R 9 54
OMEPRAZOLE 288 140 10 4
HYDROCHLOROTHIAZIDE 276 158 11 11
METOPROLOL TARTRATE 265 137 12 12
TIZANIDINE HCL 243 32 13 91
METFORMIN HCL 240 118 14 8
TRAMADOL HCL 237 85 15 13
PROAIR HFA 229 70 16 38
IBUPROFEN 197 45 17 66
POTASSIUM CHLORIDE 197 68 17 9
RANITIDINE HCL 156 61 19 29
NEXIUM 156 25 19 26
CYCLOBENZAPRINE HCL 149 21 R 21 37
GABAPENTIN 138 29 22 10
ATORVASTATIN CALCIUM 136 80 23 15
FLUTICASONE PROPIONATE 135 20 24 27
MELOXICAM 126 63 25 18
GLIPIZIDE 124 50 26 57
AZITHROMYCIN 122 36 27 39
CLONIDINE HCL 110 43 28 42
PRAVASTATIN SODIUM 108 50 29 17
VERAPAMIL ER 107 37 30 100
BYSTOLIC 104 33 31 133
PHENYTOIN SODIUM EXTENDED 99 0 32 126
BUSPIRONE HCL 97 33 33 96
VENTOLIN HFA 88 35 34 122
CARVEDILOL 87 38 35 21
LYRICA 86 46 36 62
LANTUS SOLOSTAR 83 12 37 135
ADVAIR DISKUS 82 38 38 43
PRENATAL PLUS 75 23 39 254
ABILIFY 71 20 40 123
CITALOPRAM HBR 71 32 40 14
TRAZODONE HCL 69 11 42 32
PROMETHAZINE HCL 65 20 R 43 69
LEVOTHYROXINE SODIUM 64 56 44 3
FLUOXETINE HCL 61 14 45 44
ENALAPRIL MALEATE 60 24 46 56
AMITRIPTYLINE HCL 60 17 R 46 64
PLAVIX 58 38 48 49
ATENOLOL 57 33 49 22
CLOPIDOGREL 56 28 50 30
LANTUS 56 24 50 46
LIPITOR 56 20 50 116
SERTRALINE HCL 54 33 53 24
CIPROFLOXACIN HCL 53 16 54 58
SYMBICORT 53 32 54 176
SULFAMETHOXAZOLE-TRIMETHOPRIM 53 20 54 71
NIFEDIPINE ER 50 36 57 185
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 17, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.